CN104547475A - Medicine for treating excess yang syndromes - Google Patents
Medicine for treating excess yang syndromes Download PDFInfo
- Publication number
- CN104547475A CN104547475A CN201510006417.3A CN201510006417A CN104547475A CN 104547475 A CN104547475 A CN 104547475A CN 201510006417 A CN201510006417 A CN 201510006417A CN 104547475 A CN104547475 A CN 104547475A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- disease
- excess syndrome
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicine for treating excess yang syndromes. The medicine is prepared from the following components in parts by mass: 10 parts of radix bupleuri, 20 parts of radix astragali, 10 parts of pinellia tuber, 10 parts of coptis root, 15 parts of golden cypress, 15 parts of peony tree root bark, 30 parts of buffalo horn, 30 parts of dried radix rehmanniae, 20 parts of figwort root, 15 parts of rhizoma anemarrhenae and 15 parts of weeping forsythiae capsule. The medicine for treating excess yang syndromes has a good curative effect on all inflammations, fire symptoms and even excess heat type cancers belonging to the excess yang syndromes; the medicine is capable of clearing away heat and toxic materials, softening hardness to dissipate stagnation and tonifying healthy qi, and in the later period, a medicine for treating deficient yin syndromes is combined to enhance the immunity; the two medicines are combined to strengthen the body resistance and remove pathogenic factors, thereby achieving the purpose of curing.
Description
Technical field
The present invention relates to a kind of technical field of Chinese medicines, be specifically related to a kind of medicine for the treatment of excess syndrome sun disease.
Background technology
Chinese herbal medicine is as the rarity of the Chinese nation, and it has special health-care treatment to human body illness, and different herbal prescriptions has different curative effects to different diseases.The meaning of the prescription pill of Six Ingredients warning Six-element of the large invigorating the liver and kidney of Han dynasty Zhang Zhongjing and without the side of Six-element.The traditional Chinese medical science thinks that internal organs belong to cloudy, and functional activity belongs to sun, mutually grows growth and decline, this organic conception, overweights reinforcing the heart Liver and kidney lung spleen YIN nourishing, but must accomplish to grow and oiliness, mends and not dry, and the negative and positive of each internal organs keep balance.Human body, it is interaction between two asthenia conditions that disease produces, and first positive QI-insufficiency, any disease just can be taken advantage of a weak point.Chinese prescription of the prior art is mostly for consistent two kinds of diseases, and also uncommon with a Treated with Chinese Decoction various diseases.
Due to traditional Chinese medical science forked rubbing, a lot of disease all causes because of yang imbalance, if set about from differentiation of syndromes of YIN and YANG, cause of disease system is attributed to negative and positive, thus disease can be classified as cloudy disease and positive disease, after sorting out like this, thus can realize utilizing a kind of prescription therapeutic to belong to the various diseases of cloudy disease, or utilize a kind of prescription therapeutic to belong to the various diseases of positive disease, this is in the traditional Chinese medical science, can realize.
The traditional Chinese medical science says negative and positive, and positive disease and excess syndrome, derive from dampness-heat of the liver, heart channel excess-heat, and liver is the mother of the heart, wood generating fire, the i.e. Liver Channel excess-heat telepathy bag then prosperous aphtha of the mouth and tongue of heart-fire, whole body pruritus, appearance is crimson, and body temperature is higher, and Liver Channel excess-heat, then Light-headedness, eye mouth ears etc. are serious or hemorrhage, and xerostomia is bitter, blood pressure rising etc.Gather human body a part as damp and hot and form tumor, or become pathological changes and form cancer, but be deficiency in origin and excess in superficiality after all, Therapeutic Principle is heat-clearing and toxic substances removing, hard masses softening and resolving, takes into account healthy energy.
Summary of the invention
The object of this invention is to provide a kind of medicine for the treatment of excess syndrome sun disease, realize the various diseases being belonged to excess syndrome sun disease by a kind of prescription therapeutic.
Technical scheme of the present invention is as follows:
The present invention proposes a kind of medicine for the treatment of excess syndrome sun disease, this medicine is made up of following composition: Radix Bupleuri, the Radix Astragali, the Rhizoma Pinelliae, Rhizoma Coptidis, Cortex Phellodendri, Cortex Moutan, Cornu Bubali, the Radix Rehmanniae, Radix Scrophulariae, the Rhizoma Anemarrhenae, Fructus Forsythiae.Further, it is made up of the component of following quality proportioning: Radix Bupleuri 10 parts, the Radix Astragali 20 parts, the Rhizoma Pinelliae 10 parts, Rhizoma Coptidis 10 parts, Cortex Phellodendri 15 parts, Cortex Moutan 15 parts, Cornu Bubali 30 parts, 30 parts, the Radix Rehmanniae, Radix Scrophulariae 20 parts, the Rhizoma Anemarrhenae 15 parts, Fructus Forsythiae 15 parts.
Thin solution: Radix Bupleuri, the Radix Astragali, Rhizoma Pinelliae treating SHAO YANG disease by mediation depressed liver-energy dispersing and QI regulating in side, Cornu Bubali, Rhizoma Coptidis, Cortex Phellodendri, Cortex Moutan, Fructus Forsythiae purging liver-fire, kill residual poison.The Radix Rehmanniae, Radix Scrophulariae, Rhizoma Anemarrhenae replenishing YIN and removing heat removing heat from blood, thus the object reaching treatment excess syndrome sun disease.As face aphtha of the mouth and tongue, inflamed eyes hyperemia, ear is suppurated and is swollen and ache, allergic rhinitis etc.As: gastric cancer, oral cancer, cholecystitis, pancreatitis, rectal cancer, women mastitis, breast carcinoma, hysteromyoma, uterus carcinoma have special good effect.
Merit attention, interior through cloud, positive person's the moon, cloudy person's sun, heavy and subtract it, excess syndrome of blood should be treated by blood letting, the deficiency of vital energy should then draw it, again the gathering of cloud heresy, and its gas must void, cancer is comprised to all excess syndromes, middle and late stage not from the medicine controlling deficiency syndrome, Gu just uncharming thus reaching healing object.
Therefore, the application that the invention allows for the application of medicament composing prescription in the medicament preparing treatment excess syndrome sun disease oral cancer or gastric cancer of this treatment excess syndrome sun disease, the application in the medicament of the positive disease hysteromyoma of preparation treatment excess syndrome, the application in the medicament of preparation treatment excess syndrome sun disease breast carcinoma and treat in preparation in the medicament of excess syndrome sun disease rectal cancer.
Certainly, a lot of disease is all had imagination in reality and reality in imagination, therefore deficiency and excess with the same severity occurring at the same time in the treatment, dialectical treatment.Therefore, the invention allows for a kind of medicine for the treatment of the cloudy disease of deficiency syndrome, to combine with the medicine of this treatment excess syndrome sun disease of the present invention.The medicine of the cloudy disease of this treatment deficiency syndrome is such: it is made up of the component of following mass fraction:: the Rhizoma Atractylodis Macrocephalae 15 parts, Radix Panacis Quinquefolii 15 parts, 15 parts, Poria, Radix Asparagi 15 parts, Radix Ophiopogonis 15 parts, 30 parts, the Radix Rehmanniae, Carapax et Plastrum Testudinis 30 parts, Carapax Trionycis 30 parts, Fructus Lycii 30 parts, Semen Platycladi 30 parts, Fructus Corni 30 parts, Radix Salviae Miltiorrhizae 30 parts, the Radix Paeoniae Alba 30 parts, 10 parts, Radix Glycyrrhizae.
With the medicine for the treatment of excess syndrome sun disease of the present invention, combine with the medicine of the cloudy disease of above-mentioned treatment deficiency syndrome, carry out coordinating YIN and YANG, just can realize, to the treatment of the most of disease in world, realizing the object of a prescription therapeutic various diseases.
Provide several case below, to verify the application of the medicine of this treatment excess syndrome sun disease of the present invention:
Case 1:
The present inventor Jiang Huai, man, 62 years old, people from Renhuai City, Guizhou Province, occupation was Chinese physician, and hospital diagnosis is oral cancer, gastric cancer.Medical history: once acutely have a stomachache when 30 years old, black stool for several times, is fallen in a swoon on ground, is gastric ulcer at Guiyang Medical College do gastroscopy.Inventor uses tcm theory deficiency syndrome should be treated by tonifying method sthenia syndrome requiring purgation, and Therapeutic Principle's liver heat removing stomach function regulating stops blooding, and easing the affected liver consolidates.By YIN syndrome YANG syndrome two, side share, and fully recovers after January.Within 40 years old, recur again second time, the state of an illness and Therapeutic Method identical with above.When 50 years old, the state of an illness recurs again, features that symptom is more: oral ulcer point grows several places tumor, and just as petal, diameter about 1mm, gastroscopy, ulcer point is the same with oral cavity is diagnosed as that to suffer from cancer early stage.Treat through January with the medicine for the treatment of excess syndrome sun disease of the present invention, be almost recovered, without stomachache, without melena.Rear combination is built up resistance the medicine long-term taking of the cloudy disease of above-mentioned treatment deficiency syndrome of immunity, and body weight is increased to more than 130 jin, and muscle power strengthens, the people at the strong mistake of various function general age.
Summary: oral cancer, gastric cancer, shape, can be implicative of each other as brother, can recur separately again, and medical history longer be one of cancer district occurred frequently refractory.When as vigorous in pathogen, can not control to occur oral cavity dysphagia severe pain, then accompany stomachache, because not taking food all day, empty by consolidation, can lethally die in a few days.When serious, with the dose of the medicine ordinary person five times for the treatment of excess syndrome sun disease of the present invention, can need pull through.The drug combination of the cloudy disease of the treatment deficiency syndrome consolidated with enriching yin and nourishing kidney again, thus turn danger into safety.
Case 2:
Zhang, female, 40 years old, people from Renhuai City, Guizhou Province, Renhuai City hospital diagnosis was hysteromyoma, and diameter 5 reaches .8mm.With this medicine for the treatment of excess syndrome sun disease of the present invention and the drug combination of the cloudy disease for the treatment of deficiency syndrome, the drug dose of wherein treating excess syndrome sun disease is the twice of the medicine of the cloudy disease of quality deficiency syndrome, more than January, again carries out uterus ultrasound diagnosis, without muscular tumor, also without any pain.Two medicine first quarter moons are taken again by same dosage, with solid aftereffect, rear recovery from illness.A next year raw boy, the whole family likes.
Case 3:
Hu, female, 35 years old is breast carcinoma through Guiyang Medical College inspection, diameter 3mm × 3mm, swells and ache violent.Speed is with more than medicine January for the treatment of excess syndrome of the present invention sun disease, and tumor disappearance, the softening recovery from illness of enclosed mass, does not recur for 3 years so far.
Case 4:
Chen, man, 65 years old, be rectal cancer late period after diagnosing, treat at national various big hospital, operation many times, every day hurt like hell, hip can not descend seat.After having eaten the medicine for the treatment of excess syndrome sun disease of the present invention, hip energy seat stool, pain is slightly slow.By the medicine escalated dose for the treatment of excess syndrome of the present invention sun disease and the medicine of joining the cloudy disease for the treatment of deficiency syndrome that yin nourishing consolidates with eating life-saving for many years.
Such as: oral ulcer, toothache, pink eye disease, epistaxis, otalgia, hand-foot-mouth disease, cholecystitis, pancreatitis etc., every gallbladder meridian excess-heat upstream or downstream, the cured substance rate taking this treatment excess syndrome sun disease of the present invention can reach more than 90%.
The medicine of this treatment excess syndrome sun disease of the present invention, to the inflammation, the fiery disease even excess-heat type cancer that belong to excess syndrome sun disease, all there is good curative effect, it passes through heat-clearing and toxic substances removing, hard masses softening and resolving, takes into account healthy energy, and the later stage is again in conjunction with the medicine enhancing immunity of the cloudy disease for the treatment of deficiency syndrome of the present invention's proposition, two medicines share, Gu just uncharming thus reaching healing object.
Detailed description of the invention
Below in conjunction with embodiment, the present invention is described in further detail.
Embodiment 1:
Selected first-class Chinese crude drug Radix Bupleuri 15g, Radix Astragali 20g, Rhizoma Pinelliae 15g, Rhizoma Coptidis 10g, Cornu Bubali 30g, Radix Rehmanniae 30g, Cortex Moutan 20g, Rhizoma Anemarrhenae 15g, Cortex Phellodendri 20g, Fructus Forsythiae 20g, Radix Scrophulariae 20g, remove slag dregs's poor products, hyperthermia drying or dry, and pulverizing, incapsulates.1 capsules loads medicated powder 0.5g.
Instructions of taking: adult every day three times, each five.Child is cut down according to the circumstance, and seriously ill meal with wine adds.Various excess syndrome cancer consumption adult can 1 ~ 5 times.Note, the state of an illness alleviates and should subtract, should not long clothes.
Embodiment 2:
Selected first-class Chinese crude drug Radix Bupleuri 10g, Radix Astragali 20g, Rhizoma Pinelliae 10g, Rhizoma Coptidis 10g, Cornu Bubali 30g, Cortex Moutan 15g, Radix Rehmanniae 30g, Rhizoma Anemarrhenae 15g, Cortex Phellodendri 15g, Fructus Forsythiae 15g, Radix Scrophulariae 20g, remove slag dregs's poor products, hyperthermia drying or dry, and pulverizing, incapsulates.1 capsules loads medicated powder 0.5g.
Instructions of taking: adult every day three times, each five.Child is cut down according to the circumstance, and seriously ill meal with wine adds.Various excess syndrome cancer consumption adult can 1 ~ 5 times.Note, the state of an illness alleviates and should subtract, should not long clothes.
Certainly, more than just embody rule example of the present invention, the technical scheme that the present invention also has other embodiment, all employings to be equal to replacement or equivalent transformation to be formed, all drops within protection domain of the presently claimed invention.
Claims (6)
1. treat a medicine for excess syndrome sun disease, it is characterized in that: this medicine is made up of following composition: Radix Bupleuri, the Radix Astragali, the Rhizoma Pinelliae, Rhizoma Coptidis, Cortex Phellodendri, Cortex Moutan, Cornu Bubali, the Radix Rehmanniae, Radix Scrophulariae, the Rhizoma Anemarrhenae, Fructus Forsythiae.
2. treat a medicine for excess syndrome sun disease, it is characterized in that: it is made up of the component of following mass fraction: Radix Bupleuri 10 parts, the Radix Astragali 20 parts, the Rhizoma Pinelliae 10 parts, Rhizoma Coptidis 10 parts, Cortex Phellodendri 15 parts, Cortex Moutan 15 parts, Cornu Bubali 30 parts, 30 parts, the Radix Rehmanniae, Radix Scrophulariae 20 parts, the Rhizoma Anemarrhenae 15 parts, Fructus Forsythiae 15 parts.
3. the application of medicament composing prescription in the medicament preparing treatment excess syndrome sun disease oral cancer or gastric cancer of the treatment excess syndrome sun disease of claim 2.
4. the application of the prescription of the medicine of the treatment excess syndrome sun disease of claim 2 in the medicament of preparation treatment excess syndrome sun disease hysteromyoma.
5. the application of the prescription of the medicine of the treatment excess syndrome sun disease of claim 2 in the medicament of preparation treatment excess syndrome sun disease breast carcinoma.
6. the application of the prescription of the medicine of the treatment excess syndrome sun disease of claim 2 in the medicament of preparation treatment excess syndrome sun disease rectal cancer.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510006417.3A CN104547475A (en) | 2015-01-07 | 2015-01-07 | Medicine for treating excess yang syndromes |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510006417.3A CN104547475A (en) | 2015-01-07 | 2015-01-07 | Medicine for treating excess yang syndromes |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104547475A true CN104547475A (en) | 2015-04-29 |
Family
ID=53065246
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510006417.3A Pending CN104547475A (en) | 2015-01-07 | 2015-01-07 | Medicine for treating excess yang syndromes |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104547475A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112675253A (en) * | 2021-01-25 | 2021-04-20 | 汪伦贵 | External traditional Chinese medicine liquid for targeted therapy of internal cancer and tumor, preparation method and application |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104056030A (en) * | 2013-03-21 | 2014-09-24 | 申宏 | Dietotherapy composition capable of clearing heat and detoxifying |
-
2015
- 2015-01-07 CN CN201510006417.3A patent/CN104547475A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104056030A (en) * | 2013-03-21 | 2014-09-24 | 申宏 | Dietotherapy composition capable of clearing heat and detoxifying |
Non-Patent Citations (1)
Title |
---|
郁仁存: "《郁仁存中西医结合肿瘤学》", 31 October 2008, 中国协和医科大学出版社 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112675253A (en) * | 2021-01-25 | 2021-04-20 | 汪伦贵 | External traditional Chinese medicine liquid for targeted therapy of internal cancer and tumor, preparation method and application |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103705897B (en) | A kind of cancer relieves the pain plaster | |
CN102614442B (en) | Traditional Chinese drug capsules with effects of immunity enhancing, blood reinforcing and antiemesis | |
CN103432545A (en) | Medicament for allaying fever of child and preparation method thereof | |
CN104082745A (en) | Medicated food for conditioning blood-stasis constitution and improving immune adjustment capability and preparation method of medicated food | |
CN102370878A (en) | Chinese medicinal oral preparation for treating aphthous stomatitis | |
CN105250890A (en) | Traditional Chinese medicine for treating hyperlipidemia | |
CN104958448A (en) | Medicine for treating puerperal infection | |
CN104225166A (en) | Chinese medicine composition for treating amenorrhea and preparation method thereof | |
CN106728694A (en) | A kind of tumor post-operation patients ' recovery Chinese medicine preparation and preparation method thereof | |
CN102920965A (en) | Traditional Chinese medicine water-bindered pill for treating advanced lung cancer | |
CN102784315B (en) | Chinese patent medicine for treating chronic myeloid leukemia | |
CN102423481B (en) | Medicine for treating diabetes and preparation method thereof | |
CN104547475A (en) | Medicine for treating excess yang syndromes | |
CN103251893B (en) | Traditional Chinese medicine composition for treating male sterility | |
CN102631584B (en) | Traditional Chinese medicine composition for treating idiopathic thrombocytopenic purpura | |
CN104116912A (en) | Traditional Chinese medicinal composition for rehabilitation after radiotherapy and chemotherapy of tumor patients | |
CN105267630A (en) | Traditional Chinese medicine for treating tinnitus | |
CN103656199B (en) | A kind of Chinese medicine for the treatment of deficiency of kidney yin syndrome cough | |
CN104116908A (en) | A traditional Chinese medicine decoction for treating arrhythmia | |
CN103893644A (en) | Traditional Chinese medicine water pill preparation for treating advanced lung cancer | |
CN103212044A (en) | Traditional Chinese medicine composition for treating cardiovascular diseases | |
CN102284023A (en) | Chinese medicinal composition for treating asthma | |
CN101953994B (en) | Chinese medicament for treating luekopenia after concurrent chemoradiotherapy | |
CN105395883A (en) | Traditional Chinese medicine for curing anemia | |
CN105267836A (en) | Traditional Chinese medicine for treating coronary heart disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150429 |